Patricia Ilhan died at 62 after a battle with cancer, ending the life of the Melbourne philanthropist who helped back medical research and patient support in Australia. Patricia Ilhan died after a private illness that follows years of giving tied to her family’s experience with severe food allergies.
Patricia Ilhan and the foundation
Ilhan established the Australian Food Allergy Foundation after her family discovered that one of their daughters suffered from severe, life-threatening anaphylaxis to tree nuts. She started the foundation with an initial $1 million personal endowment, and its aim was to fund scientific research, improve clinical practices and seek a cure for anaphylaxis.
That work made her a quiet force behind a cause that began in her own home. Her philanthropy was not limited to one institution, but the foundation became the clearest expression of the practical help she chose to fund.
John Ilhan and 2007
Patricia Ilhan was the widow of John “Crazy John” Ilhan, the telecommunications tycoon who died in 2007 at the age of 42 after suffering a fatal heart attack. Her name remained closely linked to his after his death, but her own public role centered on philanthropy rather than business.
The scale of that wealth was part of the backdrop to her giving: John Ilhan built hundreds of millions of dollars in value, and Patricia Ilhan used part of that legacy to support causes with direct medical consequences for families and patients.
Peter MacCallum Cancer Centre
Ilhan later became a patron of the Peter MacCallum Cancer Centre, where her financial backing supported advanced oncological research and critical support services for patients. Her death now closes that line of support from a donor whose giving reached both allergy research and cancer care.
For the organizations tied to her name, the immediate change is personal rather than procedural: one of their most prominent patrons is gone, and the record of her giving now stands as the measure of what she built. Her family’s experience with anaphylaxis and her later support for cancer research shaped a philanthropic path that ended at 62.
